Near tetraploid prostate carcinoma: Methodologic and prognostic aspects

BACKGROUND The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1996-10, Vol.78 (8), p.1748-1755
Hauptverfasser: Forsslund, Gun, Nilsson, Bo, Zetterberg, Anders
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1755
container_issue 8
container_start_page 1748
container_title Cancer
container_volume 78
creator Forsslund, Gun
Nilsson, Bo
Zetterberg, Anders
description BACKGROUND The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of treatment. Tumors with DNA values in the tetraploid region (around 4c) present a diagnostic problem. Such DNA distributions may clearly represent aneuploid tumors with an unfavorable prognosis. However, a 4c distribution may conversely represent a tetraploid tumor (possibly a polyploid variant of the diploid tumor) with a favorable prognosis. Previous data from our laboratory indicate the existence of such a tetraploid subgroup. The goal of the current study was to investigate the diagnostic problem of 4c tumors in greater detail. METHODS Ploidy classification of cytologic smears by image cytometry was performed in a retrospective study of 334 patients with hormonally treated prostate carcinoma. Follow‐up time was 30 years or until death. RESULTS Three ploidy types were defined: near‐diploid (D type), near‐tetraploid (T type), and highly aneuploid (A type). Tumors with a modal value within the tetraploid region were found in 27% (92 cases) of the total material. Of these, 9% were defined as T type and 18% as A type. Overall, 37% of the tumors were classified as D type, 9% as T type, and 54% as A type. Of the A type tumors, one‐third had modal DNA values in the tetraploid (4c) region. Multivariate analysis showed a statistically significant difference between A type tumors and D and T type, but not between D type and T type. Both D and T type tumors progressed slowly and killed the patients 5 to 30 years after diagnosis, whereas A type tumors progressed rapidly and killed the patients within 6 years of diagnosis. CONCLUSIONS By image cytometry, prostate carcinoma can be divided into three ploidy types: D, T, and A type. Biologically, however, the tumors fall into only two groups: low grade malignant, pseudodiploid tumors of D or T type, and high grade malignant, highly aneuploid tumors of A type. Cancer 1996;78:1748‐55.
doi_str_mv 10.1002/(SICI)1097-0142(19961015)78:8<1748::AID-CNCR15>3.0.CO;2-Y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78418394</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78418394</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3165-6b61ec71da6eee3a3696d1c6a5db37a71a6d843137d7c6854ab28bdcc5f202753</originalsourceid><addsrcrecordid>eNqFkF1r2zAUhsXY6NJ2P2HgizHaC2f6sD6cjUHw2i7QNbAPWNjF4VhSOhfHziyH0n8_efFys0GvxNF59PLqIWTO6JRRyt-cfVkUi3NGc51SlvEzlueKUSbPtZmZd0xnZjabLz6kxU3xmcn3YkqnxfItT1dPyOTw6imZUEpNKjPx_Tk5DuEujppLcUSOjJE5M2ZCrm48dknv-w63dVu5ZNu1ocfeJxY7WzXtBmfJJ9__bF1bt7eVTbD5A902kRvGsPW2D6fk2Rrr4F-M5wn5dnnxtfiYXi-vFsX8OrWCKZmqUjFvNXOovPcChcqVY1ahdKXQqBkqZzLBhHbaKiMzLLkpnbVyzSnXUpyQ1_vcWOHXzoceNlWwvq6x8e0ugDYZMyLPIrjagzZ-KHR-Dduu2mD3AIzCIBlgkAyDLhh0wV_JMQMMDJIBomTYSwYBFIolcFjF7JdjiV258e6QPFqN-1fjHoPFet1hY6twwAQXmmc6Yj_22H1V-4d_-j1e77_txhvxG-HlplA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78418394</pqid></control><display><type>article</type><title>Near tetraploid prostate carcinoma: Methodologic and prognostic aspects</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Forsslund, Gun ; Nilsson, Bo ; Zetterberg, Anders</creator><creatorcontrib>Forsslund, Gun ; Nilsson, Bo ; Zetterberg, Anders</creatorcontrib><description>BACKGROUND The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of treatment. Tumors with DNA values in the tetraploid region (around 4c) present a diagnostic problem. Such DNA distributions may clearly represent aneuploid tumors with an unfavorable prognosis. However, a 4c distribution may conversely represent a tetraploid tumor (possibly a polyploid variant of the diploid tumor) with a favorable prognosis. Previous data from our laboratory indicate the existence of such a tetraploid subgroup. The goal of the current study was to investigate the diagnostic problem of 4c tumors in greater detail. METHODS Ploidy classification of cytologic smears by image cytometry was performed in a retrospective study of 334 patients with hormonally treated prostate carcinoma. Follow‐up time was 30 years or until death. RESULTS Three ploidy types were defined: near‐diploid (D type), near‐tetraploid (T type), and highly aneuploid (A type). Tumors with a modal value within the tetraploid region were found in 27% (92 cases) of the total material. Of these, 9% were defined as T type and 18% as A type. Overall, 37% of the tumors were classified as D type, 9% as T type, and 54% as A type. Of the A type tumors, one‐third had modal DNA values in the tetraploid (4c) region. Multivariate analysis showed a statistically significant difference between A type tumors and D and T type, but not between D type and T type. Both D and T type tumors progressed slowly and killed the patients 5 to 30 years after diagnosis, whereas A type tumors progressed rapidly and killed the patients within 6 years of diagnosis. CONCLUSIONS By image cytometry, prostate carcinoma can be divided into three ploidy types: D, T, and A type. Biologically, however, the tumors fall into only two groups: low grade malignant, pseudodiploid tumors of D or T type, and high grade malignant, highly aneuploid tumors of A type. Cancer 1996;78:1748‐55.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/(SICI)1097-0142(19961015)78:8&lt;1748::AID-CNCR15&gt;3.0.CO;2-Y</identifier><identifier>PMID: 8859188</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Carcinoma - genetics ; Carcinoma - mortality ; Carcinoma - pathology ; DNA ploidy ; DNA, Neoplasm - isolation &amp; purification ; Follow-Up Studies ; hormonal treatment ; Humans ; Image Cytometry ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Ploidies ; Prognosis ; Proportional Hazards Models ; prostate carcinoma ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - mortality ; Prostatic Neoplasms - pathology ; Retrospective Studies ; Survival Analysis ; tetraploid tumors ; Time Factors ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>Cancer, 1996-10, Vol.78 (8), p.1748-1755</ispartof><rights>Copyright © 1996 American Cancer Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3165-6b61ec71da6eee3a3696d1c6a5db37a71a6d843137d7c6854ab28bdcc5f202753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1748%3A%3AAID-CNCR15%3E3.0.CO%3B2-Y$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0142%2819961015%2978%3A8%3C1748%3A%3AAID-CNCR15%3E3.0.CO%3B2-Y$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3237247$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8859188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Forsslund, Gun</creatorcontrib><creatorcontrib>Nilsson, Bo</creatorcontrib><creatorcontrib>Zetterberg, Anders</creatorcontrib><title>Near tetraploid prostate carcinoma: Methodologic and prognostic aspects</title><title>Cancer</title><addtitle>Cancer</addtitle><description>BACKGROUND The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of treatment. Tumors with DNA values in the tetraploid region (around 4c) present a diagnostic problem. Such DNA distributions may clearly represent aneuploid tumors with an unfavorable prognosis. However, a 4c distribution may conversely represent a tetraploid tumor (possibly a polyploid variant of the diploid tumor) with a favorable prognosis. Previous data from our laboratory indicate the existence of such a tetraploid subgroup. The goal of the current study was to investigate the diagnostic problem of 4c tumors in greater detail. METHODS Ploidy classification of cytologic smears by image cytometry was performed in a retrospective study of 334 patients with hormonally treated prostate carcinoma. Follow‐up time was 30 years or until death. RESULTS Three ploidy types were defined: near‐diploid (D type), near‐tetraploid (T type), and highly aneuploid (A type). Tumors with a modal value within the tetraploid region were found in 27% (92 cases) of the total material. Of these, 9% were defined as T type and 18% as A type. Overall, 37% of the tumors were classified as D type, 9% as T type, and 54% as A type. Of the A type tumors, one‐third had modal DNA values in the tetraploid (4c) region. Multivariate analysis showed a statistically significant difference between A type tumors and D and T type, but not between D type and T type. Both D and T type tumors progressed slowly and killed the patients 5 to 30 years after diagnosis, whereas A type tumors progressed rapidly and killed the patients within 6 years of diagnosis. CONCLUSIONS By image cytometry, prostate carcinoma can be divided into three ploidy types: D, T, and A type. Biologically, however, the tumors fall into only two groups: low grade malignant, pseudodiploid tumors of D or T type, and high grade malignant, highly aneuploid tumors of A type. Cancer 1996;78:1748‐55.</description><subject>Biological and medical sciences</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - pathology</subject><subject>DNA ploidy</subject><subject>DNA, Neoplasm - isolation &amp; purification</subject><subject>Follow-Up Studies</subject><subject>hormonal treatment</subject><subject>Humans</subject><subject>Image Cytometry</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Ploidies</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>prostate carcinoma</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - mortality</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>tetraploid tumors</subject><subject>Time Factors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1r2zAUhsXY6NJ2P2HgizHaC2f6sD6cjUHw2i7QNbAPWNjF4VhSOhfHziyH0n8_efFys0GvxNF59PLqIWTO6JRRyt-cfVkUi3NGc51SlvEzlueKUSbPtZmZd0xnZjabLz6kxU3xmcn3YkqnxfItT1dPyOTw6imZUEpNKjPx_Tk5DuEujppLcUSOjJE5M2ZCrm48dknv-w63dVu5ZNu1ocfeJxY7WzXtBmfJJ9__bF1bt7eVTbD5A902kRvGsPW2D6fk2Rrr4F-M5wn5dnnxtfiYXi-vFsX8OrWCKZmqUjFvNXOovPcChcqVY1ahdKXQqBkqZzLBhHbaKiMzLLkpnbVyzSnXUpyQ1_vcWOHXzoceNlWwvq6x8e0ugDYZMyLPIrjagzZ-KHR-Dduu2mD3AIzCIBlgkAyDLhh0wV_JMQMMDJIBomTYSwYBFIolcFjF7JdjiV258e6QPFqN-1fjHoPFet1hY6twwAQXmmc6Yj_22H1V-4d_-j1e77_txhvxG-HlplA</recordid><startdate>19961015</startdate><enddate>19961015</enddate><creator>Forsslund, Gun</creator><creator>Nilsson, Bo</creator><creator>Zetterberg, Anders</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961015</creationdate><title>Near tetraploid prostate carcinoma: Methodologic and prognostic aspects</title><author>Forsslund, Gun ; Nilsson, Bo ; Zetterberg, Anders</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3165-6b61ec71da6eee3a3696d1c6a5db37a71a6d843137d7c6854ab28bdcc5f202753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - pathology</topic><topic>DNA ploidy</topic><topic>DNA, Neoplasm - isolation &amp; purification</topic><topic>Follow-Up Studies</topic><topic>hormonal treatment</topic><topic>Humans</topic><topic>Image Cytometry</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Ploidies</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>prostate carcinoma</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - mortality</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>tetraploid tumors</topic><topic>Time Factors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Forsslund, Gun</creatorcontrib><creatorcontrib>Nilsson, Bo</creatorcontrib><creatorcontrib>Zetterberg, Anders</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Forsslund, Gun</au><au>Nilsson, Bo</au><au>Zetterberg, Anders</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Near tetraploid prostate carcinoma: Methodologic and prognostic aspects</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1996-10-15</date><risdate>1996</risdate><volume>78</volume><issue>8</issue><spage>1748</spage><epage>1755</epage><pages>1748-1755</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>BACKGROUND The clinical value of DNA ploidy analysis in prostate carcinoma has been an issue for investigation for more than 2 decades. In general, diploid or pseudodiploid tumors are associated with a favorable prognosis and aneuploid tumors with an unfavorable prognosis, irrespective of type of treatment. Tumors with DNA values in the tetraploid region (around 4c) present a diagnostic problem. Such DNA distributions may clearly represent aneuploid tumors with an unfavorable prognosis. However, a 4c distribution may conversely represent a tetraploid tumor (possibly a polyploid variant of the diploid tumor) with a favorable prognosis. Previous data from our laboratory indicate the existence of such a tetraploid subgroup. The goal of the current study was to investigate the diagnostic problem of 4c tumors in greater detail. METHODS Ploidy classification of cytologic smears by image cytometry was performed in a retrospective study of 334 patients with hormonally treated prostate carcinoma. Follow‐up time was 30 years or until death. RESULTS Three ploidy types were defined: near‐diploid (D type), near‐tetraploid (T type), and highly aneuploid (A type). Tumors with a modal value within the tetraploid region were found in 27% (92 cases) of the total material. Of these, 9% were defined as T type and 18% as A type. Overall, 37% of the tumors were classified as D type, 9% as T type, and 54% as A type. Of the A type tumors, one‐third had modal DNA values in the tetraploid (4c) region. Multivariate analysis showed a statistically significant difference between A type tumors and D and T type, but not between D type and T type. Both D and T type tumors progressed slowly and killed the patients 5 to 30 years after diagnosis, whereas A type tumors progressed rapidly and killed the patients within 6 years of diagnosis. CONCLUSIONS By image cytometry, prostate carcinoma can be divided into three ploidy types: D, T, and A type. Biologically, however, the tumors fall into only two groups: low grade malignant, pseudodiploid tumors of D or T type, and high grade malignant, highly aneuploid tumors of A type. Cancer 1996;78:1748‐55.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8859188</pmid><doi>10.1002/(SICI)1097-0142(19961015)78:8&lt;1748::AID-CNCR15&gt;3.0.CO;2-Y</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1996-10, Vol.78 (8), p.1748-1755
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_78418394
source MEDLINE; Access via Wiley Online Library; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
subjects Biological and medical sciences
Carcinoma - genetics
Carcinoma - mortality
Carcinoma - pathology
DNA ploidy
DNA, Neoplasm - isolation & purification
Follow-Up Studies
hormonal treatment
Humans
Image Cytometry
Male
Medical sciences
Nephrology. Urinary tract diseases
Ploidies
Prognosis
Proportional Hazards Models
prostate carcinoma
Prostatic Neoplasms - genetics
Prostatic Neoplasms - mortality
Prostatic Neoplasms - pathology
Retrospective Studies
Survival Analysis
tetraploid tumors
Time Factors
Tumors of the urinary system
Urinary tract. Prostate gland
title Near tetraploid prostate carcinoma: Methodologic and prognostic aspects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A35%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Near%20tetraploid%20prostate%20carcinoma:%20Methodologic%20and%20prognostic%20aspects&rft.jtitle=Cancer&rft.au=Forsslund,%20Gun&rft.date=1996-10-15&rft.volume=78&rft.issue=8&rft.spage=1748&rft.epage=1755&rft.pages=1748-1755&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/(SICI)1097-0142(19961015)78:8%3C1748::AID-CNCR15%3E3.0.CO;2-Y&rft_dat=%3Cproquest_cross%3E78418394%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78418394&rft_id=info:pmid/8859188&rfr_iscdi=true